Company
About Edgewise
Management Team
Board of Directors
Scientific Advisory Board
R & D
Our Pipeline
Clinical Trials
Areas of Focus
Scientific Presentations & Publications
Patients & Families
Our Promise
Our Research
Clinical Trials
Community & Resources
Investors & News
Corporate Profile
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Financials
SEC Filings
Governance
Documents and Charters
Executive Management
Board of Directors
Committee Composition
Resources & FAQs
Investor FAQs
Investor Email Alerts
Information Request Form
Investor Contacts
Join Our Team
Contact
Company
About Edgewise
Management Team
Board of Directors
Scientific Advisory Board
R & D
Our Pipeline
Clinical Trials
Areas of Focus
Scientific Presentations & Publications
Patients & Families
Our Promise
Our Research
Clinical Trials
Community & Resources
Investors & News
Corporate Profile
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Financials
SEC Filings
Governance
Documents and Charters
Executive Management
Board of Directors
Committee Composition
Resources & FAQs
Investor FAQs
Investor Email Alerts
Information Request Form
Investor Contacts
Join Our Team
Contact
Creating lifesaving medicines for rare muscle disorders
our vision
Improve the lives of patients and families suffering from rare muscle disorders by building the world’s leading muscle-focused, precision medicine company.
latest news
Edgewise Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Mar 30, 2021
READ MORE
Edgewise Therapeutics Announces Pricing of Initial Public Offering
Mar 25, 2021
READ MORE
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
Dec 8, 2020
READ MORE
READ ALL ›
learn about our pipeline
view pipeline
2021 © Copyright. Edgewise Therapeutics. All Rights Reserved.
Privacy Policy
|
Terms of Use
.
